The University of Chicago Header Logo

Connection

Issam Awad to Magnetic Resonance Imaging

Back to Details
This is a "connection" page, showing publications Issam Awad has written about Magnetic Resonance Imaging.
Issam Awad
Connection Strength
2.645
Magnetic Resonance Imaging
  1. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging. 2018 04; 47(4):1133-1138.
    View in: PubMed
    Score: 0.262
  2. Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus. 2010 Sep; 29(3):E6.
    View in: PubMed
    Score: 0.162
  3. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery. 2008 Oct; 63(4):782-9; discussion 789.
    View in: PubMed
    Score: 0.142
  4. Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery. 2008 Oct; 63(4):790-7; discussion 797-8.
    View in: PubMed
    Score: 0.142
  5. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke. 2024 01; 55(1):31-39.
    View in: PubMed
    Score: 0.102
  6. Credulity of exploratory trials for cerebral cavernous malformations. Lancet Neurol. 2023 01; 22(1):2-3.
    View in: PubMed
    Score: 0.094
  7. Propranolol as therapy for cerebral cavernous malformations: a cautionary note. J Transl Med. 2022 04 05; 20(1):160.
    View in: PubMed
    Score: 0.090
  8. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth. J Magn Reson Imaging. 2022 05; 55(5):1440-1449.
    View in: PubMed
    Score: 0.087
  9. Commentary: Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases. Neurosurgery. 2021 09 15; 89(4):E207-E208.
    View in: PubMed
    Score: 0.087
  10. COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106101.
    View in: PubMed
    Score: 0.087
  11. Patterns of functional magnetic resonance imaging activation in association with structural lesions in the rolandic region: a classification system. J Neurosurg. 2001 Jun; 94(6):946-54.
    View in: PubMed
    Score: 0.085
  12. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Neurosurgery. 2021 02 16; 88(3):686-697.
    View in: PubMed
    Score: 0.084
  13. Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites. J Magn Reson Imaging. 2020 04; 51(4):1192-1199.
    View in: PubMed
    Score: 0.076
  14. Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention. Stroke. 1997 Jun; 28(6):1130-7.
    View in: PubMed
    Score: 0.065
  15. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. J Neurosurg. 2017 Jul; 127(1):102-110.
    View in: PubMed
    Score: 0.061
  16. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol. 2016 Jul; 37(7):1209-15.
    View in: PubMed
    Score: 0.059
  17. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015 Oct; 35(10):1632-9.
    View in: PubMed
    Score: 0.056
  18. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014 Jul; 49(7):498-504.
    View in: PubMed
    Score: 0.053
  19. Magnetic resonance diffusion-weighted imaging: sensitivity and apparent diffusion constant in stroke. Acta Neurochir Suppl (Wien). 1994; 60:207-10.
    View in: PubMed
    Score: 0.051
  20. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014 Feb; 45(2):598-601.
    View in: PubMed
    Score: 0.051
  21. Pathogenesis of subcortical hyperintense lesions on magnetic resonance imaging of the brain. Observations in patients undergoing controlled therapeutic internal carotid artery occlusion. Stroke. 1993 Sep; 24(9):1339-46.
    View in: PubMed
    Score: 0.050
  22. Application of magnetic resonance angiography to neurosurgical practice: a critical review of 150 cases. Neurol Res. 1992 Dec; 14(5):360-8.
    View in: PubMed
    Score: 0.047
  23. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.046
  24. MRI-guided stereotactic placement of depth electrodes in temporal lobe epilepsy. Br J Neurosurg. 1992; 6(1):47-53.
    View in: PubMed
    Score: 0.044
  25. A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus. J Clin Neurosci. 2011 Jun; 18(6):846-8.
    View in: PubMed
    Score: 0.042
  26. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011 Mar; 68(3):641-7; discussion 647-8.
    View in: PubMed
    Score: 0.042
  27. Intracranial cavernous angioma: a practical review of clinical and biological aspects. Surg Neurol. 2005 Apr; 63(4):319-28; discussion 328.
    View in: PubMed
    Score: 0.028
  28. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke. 2005 Apr; 36(4):872-4.
    View in: PubMed
    Score: 0.028
  29. Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials. Neurology. 2022 03 08; 98(10):e1013-e1020.
    View in: PubMed
    Score: 0.022
  30. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838.
    View in: PubMed
    Score: 0.022
  31. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. J Cereb Blood Flow Metab. 2021 11; 41(11):2944-2956.
    View in: PubMed
    Score: 0.021
  32. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance. J Neurosurg. 2020 Apr 03; 134(3):1147-1154.
    View in: PubMed
    Score: 0.020
  33. Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. Neurosurg Focus. 2020 04 01; 48(4):E12.
    View in: PubMed
    Score: 0.020
  34. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
    View in: PubMed
    Score: 0.019
  35. Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation. J Neurosurg. 1999 Oct; 91(4):626-35.
    View in: PubMed
    Score: 0.019
  36. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
    View in: PubMed
    Score: 0.018
  37. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998 Mar; 19(3):477-84.
    View in: PubMed
    Score: 0.017
  38. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol. 1996 Oct; 17(9):1733-42.
    View in: PubMed
    Score: 0.015
  39. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6620-4.
    View in: PubMed
    Score: 0.014
  40. Sensitivity of magnetic resonance diffusion-weighted imaging and regional relationship between the apparent diffusion coefficient and cerebral blood flow in rat focal cerebral ischemia. Stroke. 1995 Apr; 26(4):667-74; discussion 674-5.
    View in: PubMed
    Score: 0.014
  41. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994 Apr; 191(1):33-9.
    View in: PubMed
    Score: 0.013
  42. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
    View in: PubMed
    Score: 0.012
  43. Giant aneurysms of the proximal anterior cerebral artery: report of three cases. Neurosurgery. 1993 Jul; 33(1):120-4; discussion 124-5.
    View in: PubMed
    Score: 0.012
  44. Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations. Neurosurgery. 1993 May; 32(5):876-8.
    View in: PubMed
    Score: 0.012
  45. Symptomatic Chiari malformation in adults: a new classification based on magnetic resonance imaging with clinical and prognostic significance. Neurosurgery. 1991 May; 28(5):639-45.
    View in: PubMed
    Score: 0.011
  46. Surgical management of syringomyelia: a five year experience in the era of magnetic resonance imaging. Neurol Res. 1991 Mar; 13(1):3-9.
    View in: PubMed
    Score: 0.010
  47. Neurological deterioration in a patient with a spinal arteriovenous malformation following lumbar puncture. Case report. J Neurosurg. 1990 Apr; 72(4):650-3.
    View in: PubMed
    Score: 0.010
  48. Intraoperative determination of the extent of corpus callosotomy for epilepsy: two simple techniques. Neurosurgery. 1990 Jan; 26(1):102-5; discussion 105-6.
    View in: PubMed
    Score: 0.010
  49. Extent of resection in temporal lobectomy for epilepsy. I. Interobserver analysis and correlation with seizure outcome. Epilepsia. 1989 Nov-Dec; 30(6):756-62.
    View in: PubMed
    Score: 0.010
  50. Internal carotid artery occlusion for cavernous segment aneurysm. Neurosurgery. 1989 Sep; 25(3):398-404.
    View in: PubMed
    Score: 0.009
  51. Periventricular lesions on MRI. Facts and theories. Stroke. 1989 Jul; 20(7):963-7.
    View in: PubMed
    Score: 0.009
  52. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery. 2009 Jul; 65(1):138-44; discussion 144-5.
    View in: PubMed
    Score: 0.009
  53. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke. 2008 Dec; 39(12):3222-30.
    View in: PubMed
    Score: 0.009
  54. [Etiologic spectrum of intracerebral hemorrhage in young patients]. Neurochirurgie. 2006 Jun; 52(2-3 Pt 1):105-9.
    View in: PubMed
    Score: 0.008
  55. How frequently should we follow small asymptomatic intracranial aneurysms? Stroke. 2006 Jul; 37(7):1650; author reply 1651.
    View in: PubMed
    Score: 0.008
  56. Case problems conference: Cushing's disease and parasellar aneurysm. Neurosurgery. 2000 Dec; 47(6):1420-9.
    View in: PubMed
    Score: 0.005
  57. Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2000 Oct 31; 102(18):2300-8.
    View in: PubMed
    Score: 0.005
  58. Case problems conference: thoracic spinal cord hernia. Neurosurgery. 2000 Jun; 46(6):1408-15.
    View in: PubMed
    Score: 0.005
  59. Parenchymal perianeurysmal cystic changes in the brain: report of five cases. Radiology. 2000 Apr; 215(1):229-33.
    View in: PubMed
    Score: 0.005
  60. Hemorrhagic lesion at the tentorial incisura in a patient with facial nevus. Neurosurgery. 1999 Nov; 45(5):1216-21.
    View in: PubMed
    Score: 0.005
  61. Neonatal galenic arteriovenous malformation. Neurosurgery. 1999 Apr; 44(4):847-54.
    View in: PubMed
    Score: 0.005
  62. Ischemic stroke and intracranial multifocal cerebral arteriopathy in Williams syndrome. J Pediatr. 1995 Jun; 126(6):945-8.
    View in: PubMed
    Score: 0.004
  63. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993 May; 32(5):730-5; discussion 735-6.
    View in: PubMed
    Score: 0.003
  64. Multiple vertebral hemangiomas with neurological signs. Case report. J Neurosurg. 1992 Jun; 76(6):1025-8.
    View in: PubMed
    Score: 0.003
  65. Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
    View in: PubMed
    Score: 0.003
  66. Extent of mesiobasal resection determines outcome after temporal lobectomy for intractable complex partial seizures. Neurosurgery. 1991 Jul; 29(1):55-60; discussion 60-1.
    View in: PubMed
    Score: 0.003
  67. Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg. 1990 Oct; 73(4):555-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.